(ISPE: Tampa, FL) — The International Society for Pharmaceutical Engineering (ISPE), which provides an educational forum for the pharmaceutical industry, has brought together a substantial lineup of global regulatory officials and pharmaceutical industry leaders to be plenary speakers at the Food and Drug Administration (FDA)/ISPE co-sponsored “Redefining the ‘C’ in ‘CGMP’” conference in Baltimore on June 4–5, 2012. These top regulatory and industry professionals will speak on the key current good manufacturing practice (CGMP) issues affecting the pharmaceutical industry today.

“This first annual collaborative FDA-ISPE event is on track to become a landmark conference with unprecedented opportunities for regulators and industry professionals to engage in dialogue, solve problems, and learn from one another,” says ISPE’s president and CEO, Nancy Berg. “It’s not often that a single conference is able to present this many relevant, high-level speakers. The caliber of these speakers illustrates ISPE’s and FDA’s shared commitment to addressing quality and manufacturing challenges to ensure the safety and availability of the world’s drug supply.”

 …